Nautilus Biotechnology
Nautilus Biotechnology develops the Voyager platform, which uses Iterative Mapping technology for accurate single-molecule quantification of proteins and proteoforms. Its products are designed for researchers in drug development, biomarker discovery, and exploratory biology to provide comprehensive views of the proteome and support deep biological insights. The organization aims to revolutionize biomedicine by unlocking the complexity of the proteome to positively impact global health.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2016
- Employees
- 148
- Stage
- Public
- Members see funding amounts. .
- Founders
- Sujal Patel, Parag Mallick, PhD
Is this your organization? Claim it
Nautilus Biotechnology Reports Q3 2026: $0.2M Revenue, Nature Methods Paper, $6M ARPA-H SEEDS Award Expected
Nautilus Biotechnology reported Q3 2026 results highlighting a Nature Methods paper validating its Iterative Mapping on the Voyager platform, progress on oncology proteoform assays and a pipeline aiming for 20 assays by mid-2028, and expects up to $6 million from an ARPA-H–funded consortium (SEEDS). Revenue for the quarter was $0.2 million, primarily from grant income.
Nautilus CEO Sujal Patel Delays Biotech Product Launch to Late 2026, Lays Off 16% Workforce Amid Strategic Shift
Nautilus Biotechnology laid off 16% of its workforce and delayed its product launch to late 2026 to pursue a higher-performance proteomics platform. CEO Sujal Patel emphasized the company’s strong financial position with over $206 million in cash despite the stock price drop.
Nautilus Biotechnology Lays Off 16% of Staff, Postpones Proteome Platform Launch to Late 2026
Nautilus Biotechnology laid off 16% of its workforce to extend its cash runway into 2027 and delayed the commercial release of its proteome analysis platform until late 2026. The company aims to control operating expenses and maximize its impact on biological science, focusing on proteomics to advance drug development.
See all 41 news stories about Nautilus Biotechnology.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 4-
Sujal Patel Executive Officer, Director, Founder & CEO
-
Parag Mallick Founder & Chief Scientist
-
Anna Mowry Executive, Chief Financial Officer